Ekso Bionics Holdings, Inc.
EKSO
$12.40
$0.403.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -228.92% | 47.55% | 6.30% | 15.29% | -64.72% |
| Total Depreciation and Amortization | 22.89% | -2.65% | -0.26% | -5.03% | -2.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 393.59% | 125.38% | -448.02% | -112.55% | 1,218.06% |
| Change in Net Operating Assets | -16.07% | -25,660.00% | -100.67% | 2,778.57% | 94.02% |
| Cash from Operations | -110.14% | 40.16% | -75.27% | -37.12% | 37.07% |
| Capital Expenditure | -950.00% | 70.00% | -300.00% | 52.38% | -162.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -950.00% | 70.00% | -300.00% | 52.38% | -162.50% |
| Total Debt Issued | -99.95% | -- | -- | -- | -- |
| Total Debt Repaid | 86.51% | -641.35% | 0.32% | -0.32% | 0.32% |
| Issuance of Common Stock | -- | -- | -75.85% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 768.42% | -170.94% | -82.54% | 1,223.89% | -106.69% |
| Foreign Exchange rate Adjustments | -70.00% | -117.86% | 700.00% | 122.58% | -3,200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.37% | 10.38% | -280.14% | 186.77% | -174.74% |